Taprostene
Alternative Names: CG 4203; SE 63Latest Information Update: 20 Mar 1997
At a glance
- Originator Grunenthal
- Class Antiplatelets; Benzoic acids; Prostaglandins
- Mechanism of Action Epoprostenol agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arterial occlusive disorders; Coronary artery restenosis; Intermittent claudication; Myocardial infarction
Most Recent Events
- 20 Mar 1997 Discontinued-I for Intermittent claudication (PO)
- 20 Mar 1997 Discontinued-II for Intermittent claudication (IV)
- 20 Mar 1997 Discontinued-III for Arterial occlusive disorders in Austria (Unknown route)